MarketPulse

synergy

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Acrivon's Dual Drug Combo Shows Promise Against Cancer in Preclinical Trial

Acrivon highlights preclinical data for ACR-368 and ACR-2316 combination therapies at AACR 2026, showing synergies with checkpoint inhibitors and ADCs.
ACRVimmunotherapysynergy
The Motley FoolThe Motley Fool··Rick Orford

Amcor's Post-Merger Momentum Tests Entry Valuations for Income Investors

Amcor offers 5.3% dividend yield post-merger, but investors should evaluate if current valuations justify entry despite strong fundamentals and recent stock appreciation.
AMCRmergerdividend yield